MedCap AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MCAP.ST research report →
Companywww.medcap.se
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, and pharmaceuticals companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Northern Europe.
- CEO
- Anders Dahlberg
- IPO
- 2007
- Employees
- 570
- HQ
- Solna, SE
Price Chart
Valuation
- Market Cap
- $8.35B
- P/E
- 37.06
- P/S
- 3.85
- P/B
- 5.47
- EV/EBITDA
- 16.99
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 37.23%
- Op Margin
- 14.53%
- Net Margin
- 10.38%
- ROE
- 15.72%
- ROIC
- 10.69%
Growth & Income
- Revenue
- $2.11B · 16.67%
- Net Income
- $219.80M · 5.98%
- EPS
- $14.67 · 4.86%
- Op Income
- $300.20M
- FCF YoY
- -4.53%
Performance & Tape
- 52W High
- $677.00
- 52W Low
- $403.00
- 50D MA
- $490.35
- 200D MA
- $537.51
- Beta
- 0.47
- Avg Volume
- 18.05K
Get TickerSpark's AI analysis on MCAP.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our MCAP.ST Coverage
We haven't published any research on MCAP.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MCAP.ST Report →